MGI, a subsidiary of global genomics leader BGI Group, is bringing its genetic sequencing and laboratory automation platforms to Brazil, where the company participated in the Hospitalar conference May 21-24. MGI showcased its innovation in next generation sequencing technology and presented along with its early adopter in the local market, the Oswaldo Cruz Foundation (Fiocruz). […]
DUBLIN, Ireland, and Hørsholm, Denmark: ERS Genomics Limited and Bioneer A/S today announced the signing of a license agreement providing Bioneer access to CRISPR/Cas9 genome editing technology intellectual property. Bioneer, a Denmark based life science research and technology provider, will utilize CRISPR/Cas9 technology to generate a range of innovative human cell based disease models. Under the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio of products that serve the rapidly growing […]
DNA/RNA SHIELD™ PROTECTS BIOLOGICAL SAMPLES EVEN IN SPACE Zymo Research received recognition from NASA for their cooperation and dedication in the development of a unique sample collection tube to support human research aboard the International Space Station. IRVINE, Calif. — Zymo Research recently received recognition and appreciation from the National Aeronautics and Space Administration’s Human Research […]
Novel bioinformatics-powered multi-guide design guarantees gene knockouts in any human-derived cell type, eliminating trial-and-error in CRISPR guide design REDWOOD CITY, California — Synthego, a leading genome engineering solutions company, today announced the launch of the Gene Knockout Kit v2. This is the only product that leverages a novel bioinformatics- powered multi-guide strategy to guarantee a gene knockout. […]
Chairman and CEO Kevin Hrusovsky to present at BIO and provide details about the HD-X launch and vision for continuing to pioneer disruption in healthcare with digital biomarkers Billerica, Mass. – Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, announced that it issued approximately 2.2 million […]
STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), provides an update today on its accomplishments toward commercial-scale production to support global material traceability for companies declaring sustainability goals to be achieved by 2020. High on the consumer watchlist is the plastics recycling issue. Applied DNA’s CertainT® platform provides the evidence that […]
USPTO issues sixth CRISPR-Cas9-related patent to University of California for genome editing and modulation of gene expression BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent (U.S. Patent No. 10,308,961) to University of California (UC) covering additional methods of using the CRISPR-Cas9 system. The unique methods form a toolset for both editing genes and […]
Genedata and Creoptix offer a Ready-toRun integration, allowing you to analyze data prepared with a Creoptix instrument in your Genedata Screener®. The joint solution offers: Direct analysis of Grating-Coupled Interferometry in Genedata Screener Sample data association across systems and characterization techniques Reduced set-up and routine analysis times Scale Up Your Data Analysis to Match […]
Chengdu, China–HitGen Inc today announced that it has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of interest to Gilead. In this collaboration, HitGen will apply its technology platform, based on DNA-encoded library design, synthesis and interrogation, to discover novel leads. Under the terms of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
